Irl B. Hirsch, MD - Program Co-Chair
University of Washington School of Medicine
Davida F. Kruger, MSN, APN-BC, BC-ADM - Program Co-Chair
Henry Ford Health
Todd Brusko, PhD
University of Florida
Luisa Duran, MD
John Muir Health
Robert Eckel, MD
University of Colorado
Carla J. Greenbaum, MD
Benaroya Research Institute
Faisal S. Malik, MD, MSHS
Seattle Children's Hospital
Janet McGill, MD, MA, FACE, FACP
Washington University School of Medicine
Eden M. Miller, DO
Diabetes and Obesity Care
Anne Peters, MD
USC Westside Center for Diabetes
Camille Powe, MD
Massachusetts General Hospital
Elizabeth R. Seaquist, MD
University of Minnesota Medical School
Carol Wysham, MD
Rockwood Clinic PS
Jill A. Weissberg-Benchell, PhD, CDCES
Northwestern University
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
- Irl B. Hirsch, MD (Co-Chair), has served as a consultant for Abbott Diabetes, Lifescan, embecta, and GWave; and received grant funding from Dexcom and Insulet Corporation.
- Todd M. Brusko, PhD has received support from Repertoire Immune Medicines, ImmunoCore, Inspira Therapeutics, Merck, SQZ Therapeutics, Rubius, Genzyme, and Quell Therapeutics
- Robert Eckel, MD has served as a board member for Novo Nordisk.
- Carla J. Greenbaum, MD has served as an advisory board member for Merck, GentiBio; Enthera Sciences, VieloBio, and Altheia Science; as consultant for AstraZeneca; and received grant funding from Bristol-Myers Squibb, Jansen Pharmaceuticals, Pfizer Inc., ProventionBio, and Intrexon.
- Janet B. McGill, MD, MA, FACE has served as a consultant for Bayer, Boehringer Ingelheim, Mannkind and Thermo Fisher; and received grant funding from Novo Nordisk and JDRF.
- Carol Wysham, MD has served as an investigator for Corcept, Eli Lilly & Company, Novo Nordisk, Vanda, and Regeneron Pharmaceuticals.
- Eden Miller, DO has served on the advisory board for Abbott, Lilly USA, Boehringer Ingelheim, Sanofi Aventis, Novo Nordisk, Merck, Bayer, Plenity; was on the Speakers Bureau for Abbott, Lilly USA, Boehringer Ingelheim, Novo Nordisk, and Bayer; and has received support research from Abbott Diabetes Care.
- Anne Peters, MD has served on an advisory board for Abbott Diabetes Care, Medscape, Novo Nordisk, Vertex, and Zealand; has served as a consultant for Blue Circle Health; has received research support from Dexcom, Insulet, Abbott Diabetes Care; and has stock with Omada Health and Teladoc
- Camille Powe, MD receives royalties for UptoDate chapters; serves as consultant for Mediflix, Inc.
- Elizabeth R. Seaquist, MD has served as an advisor for Zucara; sponsored a study group for Novo Nordisk
The following faculty reported no relevant financial relationships: Luisa A. Duran, Jill A. Weissberg-Benchell, PhD, CDCES, and Faisal S. Malik, MD, MSHS.
The following committee member who planned and reviewed content for this activity reported relevant financial relationships:
- Davida F. Kruger, MSN, APN-BC, BC-ADM (Co-Chair), has served as an advisory board member for Sanofi, Novo Nordisk, and Modular Medical.
- Irl B. Hirsch, MD (Co-Chair), has served as a consultant for Abbott Laboratories, Lifescan, embecta, and GWave; and received grant funding from Dexcom and Insulet Corporation.
The Endocrine Society staff involved in the development of this activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity is supported by educational grant from Abbott Diabetes Care, Cequr, Dexcom, Insulet, JDRF Lilly USA, Mannkind, Novo Nordisk, Provention Bio, Vertex and Tandem Diabetes.